| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avalo Therapeutics, Inc. (AVTX) has 9 insiders with recent SEC Form 4 filings, including 22 buys and 0 sells. AVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 275.0K | $4.04M | - | |
| Other | 47.8K | $702.7K | -679 | |
| CFO | 19.1K | $281.0K | - | |
| Other | 3.6K | $53.4K | - | |
| Dir | 3.2K | $46.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2023 | Caissa Capital Management Ltd. | 10% Owner | Buy | 17,500 | $3.07 | $53,671.50 | +0.7% | -91.8% | -98.2% | |
| Apr 18, 2023 | Caissa Capital Management Ltd. | 10% Owner | Buy | 25,000 | $2.95 | $73,874.00 | +1.0% | -87.8% | -98.0% | |
| Apr 11, 2023 | Caissa Capital Management Ltd. | 10% Owner | Buy | 56,329 | $2.53 | $142,516.39 | +2.3% | -88.3% | -98.0% | |
| Feb 7, 2023 | Armistice Capital, LLC56 | 10% Owner | Buy | 450,000 | $0.00 | - | +11.3% | -23.7% | -99.5% | |
| Dec 9, 2022 | Neil Garry Arthur | CEO And Chairman Of The Board | Buy | 2,083 | $4.42 | $9,206.86 | +29.2% | -53.5% | -99.0% | |
| Mar 14, 2022 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 226,000 | $0.67 | $151,946.00 | +0.2% | -31.3% | -67.4% | |
| Mar 7, 2022 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 510,000 | $0.67 | $344,132.50 | +0.4% | -48.2% | -69.2% | |
| Feb 25, 2022 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 140,000 | $0.80 | $111,806.00 | +0.1% | -59.2% | -69.5% | |
| Feb 22, 2022 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 288,000 | $0.80 | $231,563.50 | +0.2% | -60.0% | -68.5% | |
| Jan 20, 2022 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 312,000 | $0.88 | $274,486.28 | +0.2% | -30.1% | -50.1% |